Document is current
Any future updates will be listed below
-
Authors
Chen, Jinling
Xue, Lilan
Hu, Hongxia
Yin, Xiaoyan
Cao, Hui
Shen, Bang http://orcid.org/0000-0003-0103-271X
-
Funding
Funding for this research was provided by:
Guangdong major project of basic and applied basic research (2020B0301030007)
- License Information
-
More Information
Article History
Received: 28 June 2022
Accepted: 26 July 2022
First Online: 15 August 2022
Declarations
:
: All animal experiments in this study have been approved by the Scientific Ethic Committee of Huazhong Agricultural University (permit #: HZAUCA-2022-0007). Cat sera samples were collected from a local pet hospital in Wuhan and consents from cat owners were obtained before sera collection.
: Not applicable.
: A patent has been filed in China to protect the use of MIC17A in serological diagnosis of cat toxoplasmosis. An intent of collaboration with Wuhan Keqian Biology Co., Ltd. has been agreed to develop diagnostic products using MIC17A. Author Bangshen was not involved in the journal’s review or decisions related to this manuscript.
